References
- Hirsh J, Dalen J, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001; 119:8S-21S.
- Bell RG. Vitamin K and chemical carcinogenesis. Lancet. 1978; 1:1161.77457
- Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, et al. Managing oral anticoagulant therapy. Chest. 2001; 119:22S-38S.
- Palareti G, Warfarin anticoagulation in children made easier. Thromb Res. 2006; 118:667-9.1631394910.1016/j.thromres.2005.09.015
- Wessler S, Gitel SN. Warfarin. From bedside to bench. N Engl J Med. 1984; 311:645-52.10.1056/NEJM1984090631110076472343
- Busakornruangrat S, Chuansumrit A, Angchaisuksiri P, Sasanakul W, Kadekasem P. Frequencies of polymorphism associated with cytochrome p450 in Thais. Thai J Hematol Transf Med. 2006; 16:213-9.
- Klamchuen S, Chuansumrit A, Angchaisuksiri P, Sasanakul W. Frequency of polymorphisms associated with VKORC1 gene in Thai blood donors and patients receiving warfarin. Thai J Hematol Transf Med. 2008; 18:307-13.
- Sangviroon A, Panomvana D, Tassaneeyakul W, Namchaisiri J. Pharmacokinetic and pharmacodynamic variation associated with VKORC1 and CYP2C9 polymorphisms in Thai patients taking warfarin. Drug Metab Pharmacokinet. 2010; 25:531-8.10.2133/dmpk.DMPK-10-RG-05920930419
- Gaikwad T, Ghosh K, Shetty S. VKORC1 and CYP2C9 genotype distribution in Asian countries. Thromb Res. 2014; 134:537-44.10.1016/j.thromres.2014.05.02824908449
- Kuanprasert S, Dettrairat S, Palacajornsuk P, Kunachiwa W, Phrommintikul A. Prevalence of CYP2C9 and VKORC1 mutation in patients with valvular heart disease in northern Thailand. J Med Assoc Thai. 2009; 92:1597-601.20043560
- Sangkhathat S, Kusafuka T, Chengkriwate P, Patrapinyokul S, Sangthong B, Fukuzawa M. Mutations and polymorphisms of Hirschsprung disease candidate genes in Thai patients. J Hum Genet. 2006; 51:1126-32.1700907210.1007/s10038-006-0064-7
- Seng KC, Gin GG, Sangkar JV, Phipps ME. Frequency of cytochrome P450 2C9 (CYP2C9) alleles in three ethnic groups in Malaysia. Asia Pacific J Mol Biol Biotechnol. 2003; 11:83-91.
- Verbraecken J, Van de Heyning P, De Backer W, Van Gaal L. Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism. 2006; 55:515-24.
- Sermsathanasawadi N, Sritongsathian C, Pongrattanaman N, Praditsuktavorn B, Hongku K, Wongwanit C, et al. The influence of VKORC1 polymorphisms on warfarin doses in Thai patients with deep vein thrombosis. J Med Assoc Thai. 2015; 98:549-54.26219158
- Johnson JA, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, et al. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther. 2011; 90:625-9.10.1038/clpt.2011.18521900891